Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Intra-Cellular Therapies (ITCI): Raising PT On Solid PhIII Data - Cowen
-
Intra-Cellular Therapies to Present at the Cowen and Company 37th Annual Health Care Conference
-
Trading Radar for 4/28: Ford (F), Amazon (AMZN), Viacom (VIAB), LinkedIn (LNKD), Pandora (P), Aetna (AET) Report
-
Intra-Cellular Therapies to Present at the Cowen and Company 36th Annual Health Care Conference
-
Trading Radar for 2/25: Baidu (BIDU), Best Buy (BBY), Sears (SHLD), Weight Watchers (WTW) Report
-
Intra-Cellular Therapies Announces Closing of $345 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
-
Intra-Cellular Therapies Announces Closing of $345 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
-
Intra-Cellular Therapies (ITCI) Prices 6.9M Common Stock Offering at $43.50/Share
-
Intra-Cellular Therapies Prices $300 Million Public Offering of Common Stock
-
Intra-Cellular Therapies Prices $300 Million Public Offering of Common Stock
-
Intra-Cellular Therapies (ITCI) to Offer $300M in Common Stock
-
Intra-Cellular Therapies (ITCI) Commences $300M Common Stock Offering
-
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
-
Notable 52-Week Highs and Lows 9/18: (APDN) (ITCI) (CANF) Higher; (LQ) (PVA) (FMC) Lower
-
Intra-Cellular Therapies (ITCI) PT Raised to $75 at Cowen
-
Intra-Cellular Therapies (ITCI) PT More Than Doubled at Cowen
-
Fresh Off Generic Sale, Allergan (AGN) is Poised for Merger of Epic Proportions (AMGN) (ABBV)
-
Intra-Cellular Therapies Announces Closing of $130 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
-
Intra-Cellular Therapies Announces Closing of $130 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
-
Intra-Cellular Therapies (ITCI) PT Raised to $29 at Cowen
-
Intra-Cellular Therapies (ITCI) Prices 4.75M Offering at $24/Share
-
Intra-Cellular Therapies Prices $114 Million Public Offering of Common Stock
-
Intra-Cellular Therapies Prices $114 Million Public Offering of Common Stock
-
Intra-Cellular Therapies (ITCI) to Offer 4.25M Shares
-
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
-
Cowen Starts Intra-Cellular Therapies (ITCI) at Outperform